Search Results - Endovascular Today

evt | Article | May 2014 Supplement

The Distal Seal Zone in AAA Repair

A facet of EVAR that is not to be overlooked.

By Theodosios Bisdas, MD, and Giovanni Torsello, MD

evt | Article | May 2014 Supplement

The Distal Seal Zone in AAA Repair

A facet of EVAR that is not to be overlooked.

By Theodosios Bisdas, MD, and Giovanni Torsello, MD

evt | Article | May 2014 Supplement

The Distal Seal Zone in AAA Repair

A facet of EVAR that is not to be overlooked.

By Theodosios Bisdas, MD, and Giovanni Torsello, MD

evt | Article | September 2019

Indigo System for Peripheral Arterial Clot Management

With Gianmarco de Donato, MD; Theodosios Bisdas, MD; Costantino Del Giudice, MD, PhD; Katharine Lewis, MBBS, FRCR, FHEA; Mario Corona, MD; Pierleone Lucatelli, MD; and Martin Schröder, MD

evt | Article | May 2019

CLI Trial Update: The CRITISCH Registry

Investigators provide an overview of registry data examining various treatment options for patients with CLI.

By Theodosios Bisdas, MD; Giovanni Torsello, MD; and Konstantinos Stavroulakis, MD

evt | Article | July 2016

Indigo Percutaneous Mechanical Thrombectomy System

Experts discuss a potential paradigm shift in acute clot management in venous and arterial occlusions.

With Michael Lichtenberg, MD, FESC; Theodosios Bisdas, MD; Jos C. van den Berg, MD, PhD; Yann Le Bras, MD; Francois Petitpierre, MD; and Florian Wolf, MD, MBA, EBIR, EBCR

Sponsored by Boston Scientific Corporation

evt | Article | September 2017 Europe Supplement

Interim Results From the Muenster Postmarket All-Comers Registry

A look at the latest data on use of the Eluvia drug-eluting stent in challenging SFA lesions.

By Theodosios Bisdas, MD, PhD

Sponsored by Boston Scientific Corporation

evt | Article | July 2016

The Eluvia™ Drug-Eluting Vascular Stent System

New techniques and devices are extending the range of patients who can be treated by endovascular means.

With Athanasios Diamantopoulos, MD, PhD, EBIR; Theodosios Bisdas, MD, PhD; and Giovanni Torsello, MD, PhD

evt | Article | May 2018

Potential Utility of Tissue Oxygen Sensors in Perfusion Monitoring

Novel microsensing technology that reflects microvascular perfusion and oxygen supply in tissue shows promise in patients with chronic limb-threatening ischemia.

By Miguel Montero-Baker, MD; Arne Schwindt, MD; and Theodosios Bisdas, MD, PhD

evt | Article | September 2020

Roundtable Discussion: Paclitaxel in PAD: Where We Stand

A panel discussion on the current state of paclitaxel in peripheral artery disease, including how device use has changed, conversations with patients about safety and informed consent, key lessons learned, and how to move forward.

With Daniel J. Bertges, MD; Theodosios Bisdas, MD; Bruce H. Gray, DO, FSCAI, MSVM; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; and Sabine Steiner, MD; with additional commentary by Jos C. van den Berg, MD, PhD

evt | News | October 18, 2015

Bolton Medical Reports Initial Case From Limited Launch of Treo System in Europe

October 16, 2015—Bolton Medical, a subsidiary of the WerfenLife Company, announced the first commercial implantation of the Treo abdominal stent graft system was performed by Theodosios Bisdas, MD, and Professor Giovanni Torsello, MD, Director of the Center for Vascular and Endovascular Surgery at St.

evt | News | July 20, 2015

CRITISCH Registry Assesses First-Line Treatment Strategies for CLI in Germany

July 21, 2015—To address a relevant gap in evidence on the optimal treatment strategy for critical limb ischemia (CLI), an analysis of the prospective, multicenter CRITISCH registry was undertaken to assess the current practice of all first-line treatments strategies for CLI patients in German vascular centers.

evt | News | December 19, 2016

CRITISCH Registry Compares First-Line Treatments for CLI

December 20, 2016—Results from an interim analysis from the CRITISCH registry of first-line treatments in patients with critical limb ischemia (CLI) suggest that when physicians are free to individualize therapy to CLI patients, the endovascular-first approach achieved a noninferior amputation-free survival (AFS) rate compared to bypass surgery.

evt | News | June 19, 2023

Endospan’s Nexus Duo Aortic Arch Stent Graft System Evaluated in Initial Experience in Europe

June 19, 2023—Endospan announced the presentation of findings from the initial experience with its custom-made Nexus Duo aortic arch stent graft system, which is custom-built based on each patient’s anatomy and physician’s preferences to mitigate stroke risks and provide high procedural success, noted the company.

evt | Article | September 2015

Lessons From the PERICLES Registry on Complex Aortic Repair

Investigators Konstantinos P. Donas, MD, and Edward Y. Woo, MD, discuss the data from a multicenter European and United States registry of snorkel/chimney technique applications.

With Konstantinos P. Donas, MD, and Edward Y. Woo, MD

evt | Article | May 2019

Surveying the CLI Landscape

By Jos C. van den Berg, MD, PhD, and Jihad A. Mustapha, MD

evt | Article | September 2020

Update on SFA Interventions

By Yann Gouëffic, MD, PhD, and Eric A. Secemsky, MD, MSc

evt | Article | May 2018

CLI: Emerging Concepts in Care

By Jos C. van den Berg, MD, PhD, and Jihad A. Mustapha, MD, FACC, FSCAI

evt | News | July 11, 2017

German CRITISCH Registry Evaluates Endovascular CLI Treatment Outcomes in Octogenarians

July 12, 2017—Online in Journal of Endovascular Therapy, Christian Uhl, MD, et al published findings from the CRITISCH study evaluating the outcomes and periprocedural risk of endovascular revascularization in octogenarians with critical limb ischemia (CLI) compared to younger CLI patients.